Clinical Trial: Evaluation of IXCHIQ(R) Vaccine Immunogenicity

U.S., Sept. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07846293) titled 'Evaluation of IXCHIQ(R) Vaccine Immunogenicity' on Sept. 22.

Brief Summary: The goal of this clinical trial is to evaluate the quality and duration of the immune response against chikungunya virus elicited by the IXCHIQ(R) vaccine in healthy adults and adolescents. The main questions it aims to answer are:

Is the cellular immune response elicited by IXCHIQ(R) adequate for Chikungunya prevention? Is the IXCHIQ(R) vaccine safe? How does the immune response elicited by IXCHIQ(R) behave at the different time points evaluated?

Participants will:

Receive the IXCHIQ(R) vaccine; Be evaluated by medical personnel and have a blood sample ...